Lipid-based capsaicin-loaded nano-colloidal biocompatible topical carriers with enhanced analgesic potential and decreased dermal irritation

Journal of Liposome Research

Volumn 24, Issue 4, 2014, Pages 290-296

  Raza, Kaisar ^a,b   Shareef, Mohammad Afroz ^c   Singal, Parteek ^a   Sharma, Gajanand ^d   Negi, Poonam ^a   Katare, Om Prakash ^a  

^a PANJAB UNIVERSITY   (India)

^b CENTRAL UNIVERSITY OF RAJASTHAN   (India)

^c SRR College of Pharmaceutical Sciences   (India)

^d IPCA Laboratories Limited   (India)

Author keywords

Analgesic; Capsaicinoid; Carbopol gel; Radiant heat tail flick; Rheology

Indexed keywords

CAPSAICIN; LIPID; NANOCARRIER; SKIN CREAM; STEARIC ACID; ANALGESIC AGENT; COLLOID; DRUG CARRIER; LIPOSOME; NANOMATERIAL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; COLLOID; CONTROLLED STUDY; DRUG FORMULATION; DRUG RETENTION; DRUG STABILITY; DRUG TRANSPORT; ERYTHEMA; EVAPORATION; EX VIVO STUDY; FEMALE; FLOW KINETICS; HISTOPATHOLOGIC SKIN REACTION; MICROEMULSION; MOUSE; MOUSE MODEL; NANOCOLLOID; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SKIN IRRITATION; SOLID; TAIL FLICK TEST; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANALGESICS, NON-NARCOTIC; ANIMALS; CAPSAICIN; COLLOIDS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; IN VITRO TECHNIQUES; LIPOSOMES; MICE; NANOSTRUCTURES; SKIN; SKIN ABSORPTION;

EID: 84908168445     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.911314     Document Type: Article

References (22)

1. Bhatia A, Raza K, Singh B, Katare OP. (2009). Phospholipid-based formulation with improved attributes of coal tar. J Cosmet Dermatol 8:282-8.
2. Chen Y, Zhou L, Yuan L, et al. (2012). Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers. Int J Nanomed 7:3023-33.
3. Hayman M, Kam PCA. (2008). Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care 19:338-43.
4. Jenning V, Mäder K, Gohla SH. (2000). Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a H-NMR study. Int J Pharm 205:15-21.
5. Jores K, Mehnert W, Drechsler M, et al. (2004). Investigations on the structure of solid lipid nanoparticles (SLN) an oil loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 95:217-27.
6. Joshi M, Patravale V. (2006). Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm 32:911-18.
7. Joshi M, Patravale V. (2008). Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 346:124-32.
8. Junyaprasert VB, Teeranachaideekul V, Souto EB, et al. (2009). Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm 377:207-14.
9. Katare OP, Raza K, Singh B, Dogra S. (2010). Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol 76:612-21.
10. Kulkarni SK. (1999). Edition experiments on intact preparations. New Delhi, India: Vallabh Parkashan Pitam Pura.
11. Lin YK, Huang ZR, Zhuo RZ, Fang JY. (2010). Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanom 5:117-28.
12. Mason L, Moore RA, Derry S, et al. (2004). Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328:991.
13. Müller RH, Olbrich C. (1999). Solid lipid nanoparticles: phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation. Die Pharm 61:462-7.
14. Pardeike J, Weber S, Haber T, et al. (2011). Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm 31:329-38.
15. Rains C, Bryson HM. (1995). Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7:317-28.
16. Raza K, Katare OP, Setia A, et al. (2013a). Improved therapeutic performance of dithranol against Psoriasis employing systematically optimized nano-emulsomes. J Microencapsul 30:225-36.
17. Raza K, Singh B, Singla N, et al. (2013b). Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. J Drug Target 21:435-42.
18. Raza K, Singh B, Mahajan A, et al. (2011). Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 19:293-302.
19. Tamilnadu Pharmaceutical Sciences Welfare Trust. (2012). Drugs approved by the drugs controller general (India) during January 1988 to August 2006. Available from: http://www.pictrust.com/links/newdrugs.phtml [last accessed 31 Aug 2012].
20. United States Pharmacopeia (USP 30) and the National Formulary (NF 25). (2007). United States: US Pharmacopeial Convention. 1609 p.
21. US-FDA. (2009). FDA approves new drug treatment for long-term pain relief after Shingles Attacks. FDA news release. [Online] Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm191003.htm [last accessed 31 Aug 2012].
22. US-FDA. (2012). Capsaicin 8% Patch Briefing Document, Advisory Committee Meeting. US-FDA web. [Online] Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetiMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290279.pdf [last accessed 31 Aug 2012].